Stratified analysis identifies HIF-2α as a therapeutic target for highly immune-infiltrated melanomas
Amy Y. Huang, Kelly P. Burke, Ryan M. Porter, Lynn Meiger, Peter R. Fatouros, Jiekun Yang, Emily J. Robitschek, Natalie I. Vokes, Cora A. Ricker, Valeria Rosado, Giuseppe Tarantino, Jiajia Chen, Tyler J. Aprati, Marc Glettig, Yiwen He, , David Liu
The paper identifies HIF-2α as a therapeutic target for immune-infiltrated melanomas through stratified analysis of clinical and molecular data.
bioRxiv · Oct 29, 2024 · PreprintCancer Biology